The growth differentiation factor 15 (GDF15) is a novel biomarker for the use and dosing of metformin, according to a study published online Dec. 14 in Diabetes Care. 237 serum biomarkers from participants in the Outcome Reduction with Initial Glargine Intervention trial to identify markers associated with metformin dosing or use. Of the 8,401 study participants, 2,317 were taking metformin.

Read More